BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alessi M, Juhan-vague I. PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences. ATVB 2006;26:2200-7. [DOI: 10.1161/01.atv.0000242905.41404.68] [Cited by in Crossref: 229] [Cited by in F6Publishing: 89] [Article Influence: 14.3] [Reference Citation Analysis]
Number Citing Articles
1 Kothari A, Flick MJ. Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma. Int J Mol Sci 2021;22:5138. [PMID: 34066284 DOI: 10.3390/ijms22105138] [Reference Citation Analysis]
2 Borratynska A, Stopyra-Pach K, Fil K, Undas A. Impaired plasma clot lysis and its determinants in patients with obstructive sleep apnea syndrome. Blood Coagul Fibrinolysis 2016;27:892-8. [PMID: 27167858 DOI: 10.1097/MBC.0000000000000517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
3 Dutheil F, Gordon BA, Naughton G, Crendal E, Courteix D, Chaplais E, Thivel D, Lac G, Benson AC. Cardiovascular risk of adipokines: a review. J Int Med Res 2018;46:2082-95. [PMID: 28974138 DOI: 10.1177/0300060517706578] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
4 Levine JA, Oleaga C, Eren M, Amaral AP, Shang M, Lux E, Khan SS, Shah SJ, Omura Y, Pamir N, Hay J, Barish G, Miyata T, Tavori H, Fazio S, Vaughan DE. Role of PAI-1 in hepatic steatosis and dyslipidemia. Sci Rep 2021;11:430. [PMID: 33432099 DOI: 10.1038/s41598-020-79948-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Metelskaya VA, Shkolnikova MA, Shalnova SA, Andreev EM, Deev AD, Jdanov DA, Shkolnikov VM, Vaupel JW. Prevalence, components, and correlates of metabolic syndrome (MetS) among elderly Muscovites. Arch Gerontol Geriatr 2012;55:231-7. [PMID: 21955584 DOI: 10.1016/j.archger.2011.09.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
6 Campbell PT, VanWagner LB, Colangelo LA, Lewis CE, Henkel A, Ajmera VH, Lloyd-Jones DM, Vaughan DE, Khan SS. Association between plasminogen activator inhibitor-1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA. Liver Int 2020;40:1111-20. [PMID: 32090434 DOI: 10.1111/liv.14417] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lerman RH, Desai A, Lamb JJ, Chang JL, Darland G, Konda VR. A Phytochemical-rich Multivitamin-multimineral Supplement Is Bioavailable and Reduces Serum Oxidized Low-density Lipoprotein, Myeloperoxidase, and Plasminogen Activator Inhibitor-1 in a Four-week Pilot trial of Healthy Individuals. Glob Adv Health Med 2014;3:34-9. [PMID: 24808980 DOI: 10.7453/gahmj.2013.098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
8 Corban MT, Prasad A, Nesbitt L, Loeffler D, Herrmann J, Lerman LO, Lerman A. Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans. J Am Heart Assoc 2018;7:e009881. [PMID: 30371230 DOI: 10.1161/JAHA.118.009881] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Coudriet GM, Delmastro-Greenwood MM, Previte DM, Marré ML, O'Connor EC, Novak EA, Vincent G, Mollen KP, Lee S, Dong HH, Piganelli JD. Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. Antioxidants (Basel) 2017;6:E85. [PMID: 29104232 DOI: 10.3390/antiox6040085] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
10 Para I, Albu A, Porojan MD. Adipokines and Arterial Stiffness in Obesity. Medicina (Kaunas) 2021;57:653. [PMID: 34202323 DOI: 10.3390/medicina57070653] [Reference Citation Analysis]
11 Lopez-Legarrea P, Mansego ML, Zulet MA, Martinez JA. SERPINE1, PAI-1 protein coding gene, methylation levels and epigenetic relationships with adiposity changes in obese subjects with metabolic syndrome features under dietary restriction. J Clin Biochem Nutr 2013;53:139-44. [PMID: 24249967 DOI: 10.3164/jcbn.13-54] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
12 Wainberg M, Magis AT, Earls JC, Lovejoy JC, Sinnott-Armstrong N, Omenn GS, Hood L, Price ND. Multiomic blood correlates of genetic risk identify presymptomatic disease alterations. Proc Natl Acad Sci U S A 2020;117:21813-20. [PMID: 32817414 DOI: 10.1073/pnas.2001429117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Steffen LM, Cushman M, Peacock JM, Heckbert SR, Jacobs DR Jr, Rosamond WD, Folsom AR. Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology. J Thromb Haemost. 2009;7:746-751. [PMID: 19175496 DOI: 10.1111/j.1538-7836.2009.03295.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 5.8] [Reference Citation Analysis]
14 Zhao W, Ammous F, Ratliff S, Liu J, Yu M, Mosley TH, Kardia SLR, Smith JA. Education and Lifestyle Factors Are Associated with DNA Methylation Clocks in Older African Americans. Int J Environ Res Public Health 2019;16:E3141. [PMID: 31466396 DOI: 10.3390/ijerph16173141] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 12.7] [Reference Citation Analysis]
15 Bryk AH, Konieczyńska M, Polak M, Plicner D, Bochenek M, Undas A. Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long-term follow-up study. Cardiovasc Diabetol 2021;20:47. [PMID: 33602240 DOI: 10.1186/s12933-021-01230-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Khoukaz HB, Ji Y, Braet DJ, Vadali M, Abdelhamid AA, Emal CD, Lawrence DA, Fay WP. Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome. Arterioscler Thromb Vasc Biol 2020;40:1479-90. [PMID: 32268785 DOI: 10.1161/ATVBAHA.119.313775] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
17 Belalcazar LM, Ballantyne CM, Lang W, Haffner SM, Rushing J, Schwenke DC, Pi-Sunyer FX, Tracy RP; Look Action for Health in Diabetes Research Group. Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study. Arterioscler Thromb Vasc Biol 2011;31:1689-95. [PMID: 21512162 DOI: 10.1161/ATVBAHA.111.224386] [Cited by in Crossref: 39] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
18 Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Shurygina E, Barbarash O. Insulin resistance and inflammation markers in myocardial infarction. J Inflamm Res 2013;6:83-90. [PMID: 23837002 DOI: 10.2147/JIR.S43081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
19 Safwat SM, Hussein AM, Eid EA, Serria MS, Elesawy BH, Sakr HF. Dehydroepiandrosterone (DHEA) Improves the Metabolic and Haemostatic Disturbances in Rats with Male Hypogonadism. Sci Pharm 2022;90:6. [DOI: 10.3390/scipharm90010006] [Reference Citation Analysis]
20 Humphries BA, Buschhaus JM, Chen YC, Haley HR, Qyli T, Chiang B, Shen N, Rajendran S, Cutter A, Cheng YH, Chen YT, Cong J, Spinosa PC, Yoon E, Luker KE, Luker GD. Plasminogen Activator Inhibitor 1 (PAI1) Promotes Actin Cytoskeleton Reorganization and Glycolytic Metabolism in Triple-Negative Breast Cancer. Mol Cancer Res 2019;17:1142-54. [PMID: 30718260 DOI: 10.1158/1541-7786.MCR-18-0836] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
21 Beaulieu LM, Whitley BR, Wiesner TF, Rehault SM, Palmieri D, Elkahloun AG, Church FC. Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle. Bioessays 2007;29:1029-38. [PMID: 17876797 DOI: 10.1002/bies.20640] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
22 Heilbronn LK, Campbell LV, Xu A, Samocha-Bonet D. Metabolically protective cytokines adiponectin and fibroblast growth factor-21 are increased by acute overfeeding in healthy humans. PLoS One 2013;8:e78864. [PMID: 24205333 DOI: 10.1371/journal.pone.0078864] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
23 Abu-Farha M, Behbehani K, Elkum N. Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs. Cardiovasc Diabetol 2014;13:76. [PMID: 24716628 DOI: 10.1186/1475-2840-13-76] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
24 Farkas GJ, Gater DR. Neurogenic obesity and systemic inflammation following spinal cord injury: A review. J Spinal Cord Med. 2018;41:378-387. [PMID: 28758554 DOI: 10.1080/10790268.2017.1357104] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
25 Bartosiewicz A, Łuszczki E, Nagórska M, Oleksy Ł, Stolarczyk A, Dereń K. Risk Factors of Metabolic Syndrome among Polish Nurses. Metabolites 2021;11:267. [PMID: 33922860 DOI: 10.3390/metabo11050267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Zahran AM, Sayed SK, Abd El Hafeez HA, Khalifa WA, Mohamed NA, Hetta HF. Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers. Diabetes Metab Syndr Obes 2019;12:485-93. [PMID: 31043798 DOI: 10.2147/DMSO.S191750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
27 Säljö K, Apelgren P, Stridh Orrhult L, Li S, Amoroso M, Gatenholm P, Kölby L. Long-term in vivo survival of 3D-bioprinted human lipoaspirate-derived adipose tissue: proteomic signature and cellular content. Adipocyte 2022;11:34-46. [PMID: 34957918 DOI: 10.1080/21623945.2021.2014179] [Reference Citation Analysis]
28 Zagotta I, Dimova EY, Funcke JB, Wabitsch M, Kietzmann T, Fischer-Posovszky P. Resveratrol suppresses PAI-1 gene expression in a human in vitro model of inflamed adipose tissue. Oxid Med Cell Longev. 2013;2013:793525. [PMID: 23819014 DOI: 10.1155/2013/793525] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
29 Satish M, Saxena SK, Agrawal DK. Adipokine Dysregulation and Insulin Resistance with Atherosclerotic Vascular Disease: Metabolic Syndrome or Independent Sequelae? J Cardiovasc Transl Res 2019;12:415-24. [PMID: 30835048 DOI: 10.1007/s12265-019-09879-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
30 Mellendijk L, Wiesmann M, Kiliaan AJ. Impact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome. Nutrients 2015;7:9416-39. [PMID: 26580647 DOI: 10.3390/nu7115477] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
31 Chen JS, Wu CZ, Chu NF, Chang LC, Pei D, Lin YF. Association among Fibrinolytic Proteins, Metabolic Syndrome Components, Insulin Secretion, and Resistance in Schoolchildren. Int J Endocrinol 2015;2015:170987. [PMID: 26633970 DOI: 10.1155/2015/170987] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
32 Polidarová L, Sládek M, Nováková M, Parkanová D, Sumová A. Increased sensitivity of the circadian system to temporal changes in the feeding regime of spontaneously hypertensive rats - a potential role for Bmal2 in the liver. PLoS One 2013;8:e75690. [PMID: 24086613 DOI: 10.1371/journal.pone.0075690] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
33 Olson NC, Callas PW, Hanley AJ, Festa A, Haffner SM, Wagenknecht LE, Tracy RP. Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study. J Clin Endocrinol Metab 2012;97:1032-40. [PMID: 22238388 DOI: 10.1210/jc.2011-2155] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
34 Kim DH, Choi BH, Ku SK, Park JH, Oh E, Kwak MK. Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice. PLoS One 2016;11:e0153965. [PMID: 27097221 DOI: 10.1371/journal.pone.0153965] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
35 García-Prieto CF, Fernández-Alfonso MS. Caloric Restriction as a Strategy to Improve Vascular Dysfunction in Metabolic Disorders. Nutrients 2016;8:E370. [PMID: 27314388 DOI: 10.3390/nu8060370] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
36 Watanabe K, Arozal W, Tanaka H, Ma M, Satoh S, Veeraveedu PT, Kobayashi T, Oyama H, Sakaguchi Y. Beneficial Effect of Food Substitute Containing L-Arginine, omega-3 Poly Unsaturated Fatty Acid, and Ribonucleic Acid in Preventing or Improving Metabolic Syndrome: A Study in 15 Overweight Patients and a Study of Fatty Acid Metabolism in Animals. J Clin Biochem Nutr 2009;44:266-74. [PMID: 19430616 DOI: 10.3164/jcbn.08-241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Shurygina E, Barbarash O. Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction. Diabetes Metab Syndr Obes. 2013;6:293-301. [PMID: 23976861 DOI: 10.2147/DMSO.S46627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
38 Smith MR, Lee H, Fallon MA, Nathan DM. Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer. Urology 2008;71:318-22. [PMID: 18308111 DOI: 10.1016/j.urology.2007.08.035] [Cited by in Crossref: 85] [Cited by in F6Publishing: 73] [Article Influence: 6.1] [Reference Citation Analysis]
39 Ilievski V, Bhat UG, Suleiman-Ata S, Bauer BA, Toth PT, Olson ST, Unterman TG, Watanabe K. Oral application of a periodontal pathogen impacts SerpinE1 expression and pancreatic islet architecture in prediabetes. J Periodontal Res 2017;52:1032-41. [PMID: 28643938 DOI: 10.1111/jre.12474] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
40 Morange PE, Saut N, Alessi MC, Yudkin JS, Margaglione M, Di Minno G, Hamsten A, Humphries SE, Tregouet DA, Juhan-Vague I. Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study. Arterioscler Thromb Vasc Biol 2007;27:2250-7. [PMID: 17656673 DOI: 10.1161/ATVBAHA.107.149468] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
41 Samuels J, Lawson PJ, Morton AP, Moore HB, Hansen KC, Sauaia A, Schoen JA. Prospective assessment of fibrinolysis in morbid obesity: tissue plasminogen activator resistance improves after bariatric surgery. Surg Obes Relat Dis 2019;15:1153-9. [PMID: 31128997 DOI: 10.1016/j.soard.2019.03.048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
42 Chi GC, Fitzpatrick AL, Sharma M, Jenny NS, Lopez OL, DeKosky ST. Inflammatory Biomarkers Predict Domain-Specific Cognitive Decline in Older Adults. J Gerontol A Biol Sci Med Sci 2017;72:796-803. [PMID: 27522059 DOI: 10.1093/gerona/glw155] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
43 Fruzzetti F, Ghiadoni L, Virdis A, De Negri F, Perini D, Bucci F, Giannarelli C, Gadducci A, Taddei S. Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin. J Pediatr Adolesc Gynecol 2016;29:489-95. [PMID: 27018756 DOI: 10.1016/j.jpag.2016.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
44 Corgosinho FC, de Piano A, Sanches PL, Campos RM, Silva PL, Carnier J, Oyama LM, Tock L, Tufik S, de Mello MT, Dâmaso AR. The role of PAI-1 and adiponectin on the inflammatory state and energy balance in obese adolescents with metabolic syndrome. Inflammation 2012;35:944-51. [PMID: 22038064 DOI: 10.1007/s10753-011-9397-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
45 Wang L, Chen L, Liu Z, Liu Y, Luo M, Chen N, Deng X, Luo Y, He J, Zhang L, Hill MA, Li R, Wu J. PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced Obesity. Front Pharmacol 2018;9:1087. [PMID: 30319420 DOI: 10.3389/fphar.2018.01087] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
46 Hassannejad R, Sharrouf H, Haghighatdoost F, Kirk B, Amirabdollahian F. Diagnostic Power of Circulatory Metabolic Biomarkers as Metabolic Syndrome Risk Predictors in Community-Dwelling Older Adults in Northwest of England (A Feasibility Study). Nutrients 2021;13:2275. [PMID: 34209146 DOI: 10.3390/nu13072275] [Reference Citation Analysis]
47 Ryu Y, Kim SW, Kim YY, Ku SY. Animal Models for Human Polycystic Ovary Syndrome (PCOS) Focused on the Use of Indirect Hormonal Perturbations: A Review of the Literature. Int J Mol Sci 2019;20:E2720. [PMID: 31163591 DOI: 10.3390/ijms20112720] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
48 Somodi S, Seres I, Lőrincz H, Harangi M, Fülöp P, Paragh G. Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects. Int J Endocrinol 2018;2018:9596054. [PMID: 30002679 DOI: 10.1155/2018/9596054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
49 Gonias SL, Banki MA, Gilder AS, Azmoon P, Campana WM, Mantuano E. PAI1 blocks NMDA receptor-mediated effects of tissue-type plasminogen activator on cell signaling and physiology. J Cell Sci 2018;131:jcs217083. [PMID: 29930084 DOI: 10.1242/jcs.217083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
50 Smits MM, Woudstra P, Utzschneider KM, Tong J, Gerchman F, Faulenbach M, Carr DB, Aston-Mourney K, Chait A, Knopp RH, Meigs JB, Boyko EJ, Kahn SE. Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis. Ann Epidemiol 2013;23:415-21. [PMID: 23535025 DOI: 10.1016/j.annepidem.2013.03.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
51 Gruzdeva O, Uchasova E, Dyleva Y, Akbasheva O, Karetnikova V, Barbarash O. Early Effects of Treatment Low-Dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction. Front Pharmacol 2016;7:324. [PMID: 27725801 DOI: 10.3389/fphar.2016.00324] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
52 Kodaman N, Aldrich MC, Sobota R, Asselbergs FW, Brown NJ, Moore JH, Williams SM. Plasminogen Activator Inhibitor-1 and Diagnosis of the Metabolic Syndrome in a West African Population. J Am Heart Assoc 2016;5:e003867. [PMID: 27697752 DOI: 10.1161/JAHA.116.003867] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
53 Canecki-Varžić S, Prpić-Križevac I, Bilić-Ćurčić I. Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus. BMC Endocr Disord 2016;16:14. [PMID: 26940634 DOI: 10.1186/s12902-016-0094-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
54 Eren M, Boe AE, Klyachko EA, Vaughan DE. Role of plasminogen activator inhibitor-1 in senescence and aging. Semin Thromb Hemost 2014;40:645-51. [PMID: 25173500 DOI: 10.1055/s-0034-1387883] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
55 Ingelsson E, Pencina MJ, Tofler GH, Benjamin EJ, Lanier KJ, Jacques PF, Fox CS, Meigs JB, Levy D, Larson MG, Selhub J, D'Agostino RB Sr, Wang TJ, Vasan RS. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation 2007;116:984-92. [PMID: 17698726 DOI: 10.1161/CIRCULATIONAHA.107.708537] [Cited by in Crossref: 136] [Cited by in F6Publishing: 65] [Article Influence: 9.1] [Reference Citation Analysis]
56 McDaniel J, Askew W, Bennett D, Mihalopoulos J, Anantharaman S, Fjeldstad AS, Rule DC, Nanjee NM, Harris RA, Richardson RS. Bison meat has a lower atherogenic risk than beef in healthy men. Nutr Res 2013;33:293-302. [PMID: 23602247 DOI: 10.1016/j.nutres.2013.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
57 Akamatsu Y, Nishijima Y, Lee CC, Yang SY, Shi L, An L, Wang RK, Tominaga T, Liu J. Impaired leptomeningeal collateral flow contributes to the poor outcome following experimental stroke in the Type 2 diabetic mice. J Neurosci 2015;35:3851-64. [PMID: 25740515 DOI: 10.1523/JNEUROSCI.3838-14.2015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
58 Huang J, Sabater-Lleal M, Asselbergs FW, Tregouet D, Shin SY, Ding J, Baumert J, Oudot-Mellakh T, Folkersen L, Johnson AD, Smith NL, Williams SM, Ikram MA, Kleber ME, Becker DM, Truong V, Mychaleckyj JC, Tang W, Yang Q, Sennblad B, Moore JH, Williams FM, Dehghan A, Silbernagel G, Schrijvers EM, Smith S, Karakas M, Tofler GH, Silveira A, Navis GJ, Lohman K, Chen MH, Peters A, Goel A, Hopewell JC, Chambers JC, Saleheen D, Lundmark P, Psaty BM, Strawbridge RJ, Boehm BO, Carter AM, Meisinger C, Peden JF, Bis JC, McKnight B, Öhrvik J, Taylor K, Franzosi MG, Seedorf U, Collins R, Franco-Cereceda A, Syvänen AC, Goodall AH, Yanek LR, Cushman M, Müller-Nurasyid M, Folsom AR, Basu S, Matijevic N, van Gilst WH, Kooner JS, Hofman A, Danesh J, Clarke R, Meigs JB, Kathiresan S, Reilly MP, Klopp N, Harris TB, Winkelmann BR, Grant PJ, Hillege HL, Watkins H, Spector TD, Becker LC, Tracy RP, März W, Uitterlinden AG, Eriksson P, Cambien F, Morange PE, Koenig W, Soranzo N, van der Harst P, Liu Y, O'Donnell CJ, Hamsten A; DIAGRAM Consortium., CARDIoGRAM Consortium., C4D Consortium., CARDIOGENICS Consortium. Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. Blood 2012;120:4873-81. [PMID: 22990020 DOI: 10.1182/blood-2012-06-436188] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]
59 Tjärnlund-Wolf A, Brogren H, Lo EH, Wang X. Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases. Stroke 2012;43:2833-9. [PMID: 22879095 DOI: 10.1161/STROKEAHA.111.622217] [Cited by in Crossref: 56] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
60 Rautio A, Boman K, Eriksson JW, Svensson MK. Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up. Diab Vasc Dis Res 2016;13:183-91. [PMID: 26818227 DOI: 10.1177/1479164115618516] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
61 Waschki B, Watz H, Holz O, Magnussen H, Olejnicka B, Welte T, Rabe KF, Janciauskiene S. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function. Int J Chron Obstruct Pulmon Dis 2017;12:981-7. [PMID: 28356730 DOI: 10.2147/COPD.S128689] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
62 Khan SS, Shah SJ, Klyachko E, Baldridge AS, Eren M, Place AT, Aviv A, Puterman E, Lloyd-Jones DM, Heiman M, Miyata T, Gupta S, Shapiro AD, Vaughan DE. A null mutation in SERPINE1 protects against biological aging in humans. Sci Adv 2017;3:eaao1617. [PMID: 29152572 DOI: 10.1126/sciadv.aao1617] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 11.0] [Reference Citation Analysis]
63 Aburto-Mejía E, Santiago-Germán D, Martínez-Marino M, María Eugenia Galván-Plata, Almeida-Gutiérrez E, López-Alarcón M, Hernández-Juárez J, Alvarado-Moreno A, Leaños-Miranda A, Majluf-Cruz A, Isordia-Salas I. Hypofibrinolytic State in Subjects with Type 2 Diabetes Mellitus Aggravated by the Metabolic Syndrome before Clinical Manifestations of Atherothrombotic Disease. Biomed Res Int 2017;2017:6519704. [PMID: 28271069 DOI: 10.1155/2017/6519704] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
64 Buchan DS, Thomas NE, Baker JS. Novel risk factors of cardiovascular disease and their associations between obesity, physical activity and physical fitness. J Public Health Res 2012;1:59-66. [PMID: 25170447 DOI: 10.4081/jphr.2012.e11] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
65 Hoirisch-Clapauch S. Mechanisms affecting brain remodeling in depression: do all roads lead to impaired fibrinolysis? Mol Psychiatry 2021. [PMID: 34404914 DOI: 10.1038/s41380-021-01264-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Miller RA, Harrison DE, Astle CM, Bogue MA, Brind J, Fernandez E, Flurkey K, Javors M, Ladiges W, Leeuwenburgh C, Macchiarini F, Nelson J, Ryazanov AG, Snyder J, Stearns TM, Vaughan DE, Strong R. Glycine supplementation extends lifespan of male and female mice. Aging Cell 2019;18:e12953. [PMID: 30916479 DOI: 10.1111/acel.12953] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
67 Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014;2014:943162. [PMID: 24711954 DOI: 10.1155/2014/943162] [Cited by in Crossref: 847] [Cited by in F6Publishing: 833] [Article Influence: 105.9] [Reference Citation Analysis]
68 Gan YL, Fu JY, Lai OM, Chew BH, Yuen KH, Teng KT, Nesaretnam K, Selvaduray KR, Meganathan P. Effect of palm-based tocotrienols and tocopherol mixture supplementation on platelet aggregation in subjects with metabolic syndrome: a randomised controlled trial. Sci Rep 2017;7:11542. [PMID: 28912593 DOI: 10.1038/s41598-017-11813-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
69 Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population. Int J Med Sci. 2016;13:25-38. [PMID: 26816492 DOI: 10.7150/ijms.13800] [Cited by in Crossref: 182] [Cited by in F6Publishing: 171] [Article Influence: 30.3] [Reference Citation Analysis]
70 Coffey CS, Asselbergs FW, Hebert PR, Hillege HL, Li Q, Moore JH, van Gilst WH. The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels. Cardiol Res Pract 2011;2011:541467. [PMID: 21559217 DOI: 10.4061/2011/541467] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
71 Stokes S, Breheny P, Radulescu A, Radulescu VC. Impact of obesity on the risk of venous thromboembolism in an inpatient pediatric population. Pediatr Hematol Oncol 2014;31:475-80. [PMID: 24684263 DOI: 10.3109/08880018.2014.886315] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
72 Jung RG, Motazedian P, Ramirez FD, Simard T, Di Santo P, Visintini S, Faraz MA, Labinaz A, Jung Y, Hibbert B. Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis. Thromb J 2018;16:12. [PMID: 29991926 DOI: 10.1186/s12959-018-0166-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
73 Ishikawa J, Hoshide S, Eguchi K, Ishikawa S, Pickering TG, Shimada K, Kario K. Increased low-grade inflammation and plasminogen-activator inhibitor-1 level in nondippers with sleep apnea syndrome. J Hypertens 2008;26:1181-7. [PMID: 18475156 DOI: 10.1097/HJH.0b013e3282fd9949] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
74 Morrow GB, Whyte CS, Mutch NJ. A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease. Front Cardiovasc Med 2021;8:653655. [PMID: 33937363 DOI: 10.3389/fcvm.2021.653655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 de Castro J, Sevillano J, Marciniak J, Rodriguez R, González-Martín C, Viana M, Eun-suk OH, de Mouzon SH, Herrera E, Ramos MP. Implication of low level inflammation in the insulin resistance of adipose tissue at late pregnancy. Endocrinology 2011;152:4094-105. [PMID: 21914778 DOI: 10.1210/en.2011-0068] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
76 Garg MK, Dutta MK, Mahalle N. Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome. Indian J Endocrinol Metab. 2012;16:116-123. [PMID: 22276262 DOI: 10.4103/2230-8210.91206] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
77 Meltzer ME, Lisman T, Doggen CJ, de Groot PG, Rosendaal FR. Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis. PLoS Med 2008;5:e97. [PMID: 18462012 DOI: 10.1371/journal.pmed.0050097] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 5.4] [Reference Citation Analysis]
78 von Känel R, Natarajan L, Ancoli-Israel S, Mills PJ, Loredo JS, Dimsdale JE. Day/Night rhythm of hemostatic factors in obstructive sleep apnea. Sleep 2010;33:371-7. [PMID: 20337196 DOI: 10.1093/sleep/33.3.371] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
79 Rahamon SK, Fabian UA, Charles-Davies MA, Olaniyi JA, Fasanmade AA, Akinlade KS, Oyewole OE, Owolabi MO, Adebusuyi JR, Hassan OO, Ajobo BM, Ebesunun MO, Adigun K, Popoola OO, Omiyale W, Arinola OG, Agbedana EO. Changes in mediators of inflammation and pro-thrombosis after 12 months of dietary modification in adults with metabolic syndrome. Afr Health Sci 2017;17:453-62. [PMID: 29062341 DOI: 10.4314/ahs.v17i2.20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
80 Chiellini C, Cochet O, Negroni L, Samson M, Poggi M, Ailhaud G, Alessi MC, Dani C, Amri EZ. Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation. BMC Mol Biol. 2008;9:26. [PMID: 18302751 DOI: 10.1186/1471-2199-9-26] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 6.8] [Reference Citation Analysis]
81 Russo I. The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance. Scientifica (Cairo). 2012;2012:525374. [PMID: 24278711 DOI: 10.6064/2012/525374] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
82 Bucci JC, McClintock CS, Chu Y, Ware GL, McConnell KD, Emerson JP, Peterson CB. Resolving distinct molecular origins for copper effects on PAI-1. J Biol Inorg Chem 2017;22:1123-35. [PMID: 28913669 DOI: 10.1007/s00775-017-1489-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
83 Esterson YB, Kishore P, Koppaka S, Li W, Zhang K, Tonelli J, Lee DE, Kehlenbrink S, Lawrence S, Crandall J, Barzilai N, Hawkins M. Fatty acid-induced production of plasminogen activator inhibitor-1 by adipose macrophages is greater in middle-aged versus younger adult participants. J Gerontol A Biol Sci Med Sci 2012;67:1321-8. [PMID: 23089338 DOI: 10.1093/gerona/gls200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
84 Al-Hamodi ZH, Saif-Ali R, Ismail IS, Ahmed KA, Muniandy S. Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects. J Clin Biochem Nutr 2012;50:184-9. [PMID: 22573918 DOI: 10.3164/jcbn.11-48] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
85 Lalić K, Jotić A, Rajković N, Singh S, Stošić L, Popović L, Lukić L, Miličić T, Seferović JP, Maćešić M, Stanarčić J, Čivčić M, Kadić I, Lalić NM. Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity. Int J Endocrinol 2015;2015:390185. [PMID: 26089884 DOI: 10.1155/2015/390185] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
86 Tofler GH, Massaro J, O'Donnell CJ, Wilson PWF, Vasan RS, Sutherland PA, Meigs JB, Levy D, D'Agostino RB Sr. Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study. Thromb Res 2016;140:30-5. [PMID: 26896607 DOI: 10.1016/j.thromres.2016.02.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 8.2] [Reference Citation Analysis]
87 Wei Y, Liu G, Yang J, Zheng R, Jiang L, Bao P. The association between metabolic syndrome and vascular endothelial dysfunction in adolescents. Exp Ther Med 2013;5:1663-6. [PMID: 23837050 DOI: 10.3892/etm.2013.1055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
88 Basu A, Crew J, Ebersole JL, Kinney JW, Salazar AM, Planinic P, Alexander JM. Dietary Blueberry and Soluble Fiber Improve Serum Antioxidant and Adipokine Biomarkers and Lipid Peroxidation in Pregnant Women with Obesity and at Risk for Gestational Diabetes. Antioxidants (Basel) 2021;10:1318. [PMID: 34439566 DOI: 10.3390/antiox10081318] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Samarakoon R, Higgins SP, Higgins CE, Higgins PJ. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling. J Mol Cell Cardiol. 2008;44:527-538. [PMID: 18255094 DOI: 10.1016/j.yjmcc.2007.12.006] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 4.4] [Reference Citation Analysis]
90 Elhadad MA, Wilson R, Zaghlool SB, Huth C, Gieger C, Grallert H, Graumann J, Rathmann W, Koenig W, Sinner MF, Hveem K, Suhre K, Thorand B, Jonasson C, Waldenberger M, Peters A. Metabolic syndrome and the plasma proteome: from association to causation. Cardiovasc Diabetol 2021;20:111. [PMID: 34016094 DOI: 10.1186/s12933-021-01299-2] [Reference Citation Analysis]
91 Al-Hamodi Z, Saif-Ali R, Ismail IS, Ahmed KA, Muniandy S. Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in Malaysian subjects. J Biomed Biotechnol 2012;2012:234937. [PMID: 22577291 DOI: 10.1155/2012/234937] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
92 Kashino I, Nanri A, Kurotani K, Akter S, Yasuda K, Sato M, Hayabuchi H, Mizoue T. Association of dietary patterns with serum adipokines among Japanese: a cross-sectional study. Nutr J 2015;14:58. [PMID: 26058488 DOI: 10.1186/s12937-015-0046-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
93 Åkra S, Aksnes TA, Flaa A, Eggesbø HB, Opstad TB, Njerve IU, Seljeflot I. Markers of remodeling in subcutaneous adipose tissue are strongly associated with overweight and insulin sensitivity in healthy non-obese men. Sci Rep 2020;10:14055. [PMID: 32820223 DOI: 10.1038/s41598-020-71109-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
94 Yasar Yildiz S, Kuru P, Toksoy Oner E, Agirbasli M. Functional stability of plasminogen activator inhibitor-1. ScientificWorldJournal. 2014;2014:858293. [PMID: 25386620 DOI: 10.1155/2014/858293] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
95 Chukowry PS, Spittle DA, Turner AM. Small Airways Disease, Biomarkers and COPD: Where are We? Int J Chron Obstruct Pulmon Dis 2021;16:351-65. [PMID: 33628018 DOI: 10.2147/COPD.S280157] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]